Cancer Drug News Do certain diabetes drugs increase the risk of acute kidney injury in patients taking anti-cancer therapies?
Protected: Tecartus® (Brexucabtagene Autoleucel) CAR T-cell therapy now funded in Australia for adult relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r ALL)
Cancer Drug News FDA approves amivantamab-vmjw with carboplatin and pemetrexed for non-small cell lung cancer with EGFR exon 19 deletions or L858R mutations October 6, 2024 On September 19, 2024, the Food and Drug Administration approved amivantamab-vmjw with carboplatin and pemetrexed…
Cancer Drug News FDA approves selpercatinib for RET fusion-positive medullary thyroid cancer October 2, 2024 On September 27, 2024, the Food and Drug Administration granted traditional approval to selpercatinib for…
Cancer Drug News FDA approves isatuximab-irfc with bortezomib, lenalidomide, and dexamethasone for newly diagnosed multiple myeloma October 1, 2024 On September 20, 2024, the Food and Drug Administration approved isatuximab-irfc (Sarclisa, Sanofi-Aventis U.S. LLC)…
Cancer Drug News Precision drug olaparib may be effective without hormone therapy for some men with biochemically recurrent prostate cancer August 26, 2024 The anti-cancer drug olaparib may be effective in treating biochemically recurrent prostate cancer without accompanying…
Cancer Drug News FDA approves lazertinib with amivantamab-vmjw for non-small lung cancer August 23, 2024 On August 19, 2024, the Food and Drug Administration approved lazertinib (Lazcluze, Janssen Biotech, Inc.)…
FDA Approvals FDA approves new therapy for glioma patients for first time in decades August 19, 2024 Vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for patients with…
FDA Approvals FDA approves blood test as a primary screening option for colorectal cancer August 18, 2024 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has announced that the U.S.…
Cancer Drug News FDA approves vorasidenib August 17, 2024 A new drug for treatment of a type of brain cancer, called IDH-mutant low-grade glioma,…
Cancer Drug News Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma August 7, 2024 A drug that was developed to treat pancreatic cancer has now been shown to increase…
Cancer Drug News FDA approves daratumumab and hyaluronidase-fihj with bortezomib, lenalidomide, and dexamethasone for multiple myeloma August 7, 2024 On July 30, 2024, the Food and Drug Administration approved daratumumab and hyaluronidase-fihj in combination with…